Two Covid-19 drugs boost Beacon Pharma’s turnover, profits
In the January-March period of FY2020-21, the company’s net profit was Tk46.43 crore, which is 704% higher compared to the same period of the previous year
SUNDAY, JUNE 20, 2021
In the January-March period of FY2020-21, the company’s net profit was Tk46.43 crore, which is 704% higher compared to the same period of the previous year
